Conservative treatment for acute coronary syndrome in patients with type 2 diabetes mellitus

Conservative treatment for acute coronary syndrome in patients with type 2 diabetes mellitus

2 diabetes mellitus (T2DM). Dyspnea during physical exertion should be considered an anginal equivalent in patients with T2DM, and suffocation causing admission to ICU ? as a possible sign of myocardial infarction. Proximal and distal coronary lesions combined with diabetic microangiopathy compromis...

Full description

Bibliographic Details
Main Authors:	Sergey Valentinovich Kakorin, Lev Borisovich Kruglyi, Ashot Musaelovich Mkrtumyan
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2013-06-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes mellitus acute coronary syndrome myocardial infarction thromobolytic anticoagulant antiplatelet antianginal beta blocker ace hmg-coa reductase inhibitor
Online Access:	https://www.dia-endojournals.ru/jour/article/view/3755

Similar Items

Clinical and morphological characteristics, management and prognosis for acute coronary syndrome in patients with type 2 diabetes mellitus
by: Sergey Valentinovich Kakorin, et al.
Published: (2013-06-01)

The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
by: Aronow Herbert D
Published: (2002-01-01)

Are statins toxic or safe for kidney diseases? An updated mini-review study
by: Shadi Botshekan, et al.
Published: (2020-10-01)

Hesperidin Interaction with HMG-CoA-Reductase Enzyme in Hypercholesterolemia: A Study in Silico
by: Annisa Rizqi Dwi Oktaviani, et al.
Published: (2021-09-01)

Isolation and purification of 3-hydroxy-3-methylglutaryl-coenzyme A by ion-exchange chromatography
by: I P Williamson, et al.
Published: (1981-01-01)

The quantitative assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase: comparison of a thin-layer chromatographic assay with a rapid chloroform extraction assay
by: M E Ackerman, et al.
Published: (1977-05-01)

Estatinas hipolipêmicas e novas tendências terapêuticas Hypolipemic statins and new therapeutcal trends
by: Vanessa Leiria Campo, et al.
Published: (2007-04-01)

Beneficial Effects of Statins on Seizures Independent of Their Lipid-Lowering Effect: A Narrative Review
by: Arash Amanlou, et al.
Published: (2023-01-01)

Statins—From Fungi to Pharmacy
by: Anna Sadowska, et al.
Published: (2023-12-01)

Statins in clinical medicine
by: Swiss Medical Weekly
Published: (2011-11-01)

3-Hydroxy-3-methylglutaryl coenzyme A reductase in isolated villous and crypt cells of the rat ileum
by: J L Merchant, et al.
Published: (1977-11-01)

Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis
by: Ian R. Harris, et al.
Published: (1998-02-01)

Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content.
by: Heshun Chen, et al.
Published: (1993-12-01)

Gene expression of sterol regulatory element-binding proteins in hamster small intestine
by: F. Jeffrey Field, et al.
Published: (2001-01-01)

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)
by: S. B. Fitilev, et al.
Published: (2017-05-01)

Drugs for spontaneous coronary dissection: a few untrusted options
by: Ivan Ilic, et al.
Published: (2023-11-01)

The effect of the various doses of atorvastatin on renal tubular cells; an experimental study
by: Hamid Nasri, et al.
Published: (2016-07-01)

Modulating Liver Cholesterol Metabolism by 3-Iodothyronamine
by: Nasrin KAZEMIPOUR, et al.
Published: (2017-07-01)

Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
by: Man K.S. Lee, et al.
Published: (2022-07-01)

Pre and post-stroke use of statins improves stroke outcome
by: Majaz Moonis, et al.
Published: (2014-01-01)

Potential drug interactions with statins: Estonian register-based study
by: Gavronski Maia, et al.
Published: (2015-04-01)

Cerebrovascular accidents in patients with type 2 diabetes mellitus
by: Sergey Valentinovich Kakorin, et al.
Published: (2013-03-01)

Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
by: Tuuminen R, et al.
Published: (2016-05-01)

Beta adrenergic blokade in myocardial infarction
by: Yusuf, S
Published: (1980)

HEMODYNAMIC AEROBIC MECHANISMS OF EXERCISE TOLERANCE INCREASE IN STABLE ANGINA PATIENTS ON ANTIANGINAL TREATMENT
by: A. P. Vasiliev, et al.
Published: (2017-12-01)

Exploration of Binding Interaction of Steroidal Drugs with HMG-CoA Reductase for the Treatment of Breast Cancer Patients who suffer with Cardiovascular Problems: In-silico Studies
by: Varish Ahmad
Published: (2020-02-01)

Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds
by: Je-Wen Liou, et al.
Published: (2022-03-01)

The Inhibitory Effect of Biochanin A on Hepatic Cholesterol Biosynthesis in High Glucose-Induced Steatosis in HepG2 Cells
by: Negar Karimi, et al.
Published: (2020-06-01)

Influence of simvA glyzin on expression and inhibition of hmg-coa reductase in rats liver
by: Yu. I. Ragino, et al.
Published: (2015-06-01)

Evaluation of Antidiabetic potential and Hypolipidemic activity of Coccinia indica (leaves) in Diabetic Albino rats
by: Mamata Pochhi
Published: (2019-07-01)

The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
by: Huanbiao Mo, et al.
Published: (2019-01-01)

Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test
by: Dick C. Chan, et al.
Published: (2002-05-01)

Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase enzyme by dipeptides identified in dry-cured ham
by: Alejandro Heres, et al.
Published: (2021-07-01)

Bioactive Pigments of Monascus purpureus Attributed to Antioxidant, HMG-CoA Reductase Inhibition and Anti-atherogenic Functions
by: H. P. Mohankumari, et al.
Published: (2021-02-01)

Unveiling the Cardioprotective Power: Liquid Chromatography–Mass Spectrometry (LC–MS)-Analyzed <i>Neolamarckia cadamba</i> (Roxb.) Bosser Leaf Ethanolic Extract against Myocardial Infarction in Rats and In Silico Support Analysis
by: Raghupathi Niranjan Kumar, et al.
Published: (2023-10-01)

Las estatinas: Actividad biológica y producción biotecnológica.
by: Carolina Chegwin-Angarita, et al.
Published: (2012-07-01)

Las estatinas: Actividad biológica y producción biotecnológica.
by: Carolina Chegwin-Angarita, et al.
Published: (2012-08-01)

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)
by: S. В. Fitilev, et al.
Published: (2018-05-01)

Molecular docking studies of Triphala with catalytic portion of HMG-CoA reductase enzyme
by: Prasoborn Rinthong, et al.
Published: (2023-04-01)

Recurrent Stent Thrombosis Following Myocardial Infarction Associated With VITT-Like Antibodies
by: Zulqarnain Khan, MD, et al.
Published: (2024-03-01)